Kairos Pharma (KAPA) Operating Income (2023 - 2025)
Kairos Pharma's (KAPA) quarterly Operating Income came in at -$1.5 million in Q2 2025, down 555.86% YoY from $319399.2 in Q2 2024, and down 15.01% on a QoQ basis from -$1.3 million in Q1 2025.
Kairos Pharma (KAPA) Operating Income (2023 - 2025) Analysis & Trends
Kairos Pharma (KAPA) has 3 years of Operating Income data on file, last reported at -$1.5 million in Q2 2025.
- Quarterly Operating Income fell 555.86% year-over-year to -$1.5 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$4.6 million (down 141.43% YoY) and the FY2025 annual result came in at -$5.6 million, down 137.81% from the prior year.
- Operating Income slipped to -$1.5 million in Q2 2025, from -$1.3 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$222000.0 in Q2 2024 to a low of -$1.5 million in Q2 2025.
- A 3-year average of -$804500.0 and a median of -$736000.0 in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2024 — Operating Income sank 32.78% — and 2025, when it plunged 555.86%.
- Tracing KAPA's Operating Income over 3 years: stood at -$1.1 million in 2023, then plunged by 32.78% to -$1.4 million in 2024, then declined by 0.69% to -$1.5 million in 2025.
- The last three Operating Income figures came in at -$1.5 million (Q2 2025), -$1.3 million (Q1 2025), and -$1.4 million (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -1.55 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 133.12 Mn |
| 10 | Kairos Pharma | 5.39 Mn | 55,970.58 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -1.46 Mn |
| Mar 31, 2025 | -1.27 Mn |
| Dec 31, 2024 | -1.45 Mn |
| Sep 30, 2024 | -383,000.00 |
| Jun 30, 2024 | -222,000.00 |
| Mar 31, 2024 | -287,000.00 |
| Dec 31, 2023 | -1.09 Mn |
| Sep 30, 2023 | -287,000.00 |